A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- AbbVie
- Study ID
- NCT03706040
- Phase
- PHASE2
- Status
- Completed
Conditions
- Dermatitis
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Placebo — BIOLOGICALsubcutaneous (SC) injection
- Risankizumab — BIOLOGICALsubcutaneous (SC) injection
Study Details
The purpose of this study is to assess the safety and efficacy of risankizumab for the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents.
Key Dates
- Start date
- Dec 27, 2018
- Status verified
- Oct 2021
- Primary completion
- Oct 28, 2020
- Completion
- Apr 26, 2021
Study Design
- Enrollment
- 172 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: PlaceboParticipants randomized to receive placebo for 16 weeks in Period A followed by either risankizumab 150 mg or risankizumab 300 mg for 36 weeks in Period B.
- Experimental: Risankizumab 150 mgParticipants randomized to receive risankizumab 150 mg for 16 weeks in Period A followed by risankizumab 150 mg for 36 weeks in Period B.
- Experimental: Risankizumab 300 mgParticipants randomized to receive risankizumab 300 mg for 16 weeks in Period A followed by risankizumab 300 mg for 36 weeks in Period B.
Primary Outcome Measure
Percentage of Participants Achieving At Least a 75% Reduction From Baseline in Eczema Area and Severity Index (EASI 75) at Week 16 [ Time Frame: Baseline and Week 16 ]
Locations (39)
Find similar trials in Birmingham, AL
Related Studies
- Effects of Treatments on Atopic DermatitisPHASE2 · Recruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland
- A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisPHASE2 · Recruiting · Apollo Therapeutics Ltd · Birmingham, Alabama